Monthly
US$200
Billed every month
Dapoxetine Hydrochloride Tablets(盐酸达泊西汀片)
Companies, stages and changes, with each record available on this page.
Last 90 days: Marketing application approved: 1 applicationAccepted: 1 applicationNo longer listed under review: 2 applicationsNotification delivery: 1 application
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders56View records ↓
Under-review filings20View records ↓
This year’s generic filers4View records ↓
NHSA approval numbers67View records ↓
API companies with A status22View records ↓
Chemical-drug catalogue
Loaded records: 56 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 55 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 山东新华制药股份有限公司 | 山东淄博新达制药有限公司 | 国药准字H20265706 | 2026/08/25 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 济南高华制药有限公司 | 济南高华制药有限公司 | 国药准字H20265472 | 2026/08/04 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 济南高华制药有限公司 | 济南高华制药有限公司 | 国药准字H20265471 | 2026/08/04 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东百诺医药股份有限公司 | 山东明仁福瑞达制药股份有限公司 | 国药准字H20264848 | 2026/06/17 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河南华药药业有限公司 | 河南中帅药业有限公司 | 国药准字H20264834 | 2026/06/17 | 30mg（按C21H23NO 计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江莎普爱思药业股份有限公司 | 浙江莎普爱思药业股份有限公司 | 国药准字H20264855 | 2026/06/17 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东百诺医药股份有限公司 | 山东明仁福瑞达制药股份有限公司 | 国药准字H20264849 | 2026/06/17 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江莎普爱思药业股份有限公司 | 浙江莎普爱思药业股份有限公司 | 国药准字H20264854 | 2026/06/17 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 云南龙津康佑生物医药有限公司 | 昆明龙津药业股份有限公司 | 国药准字H20264322 | 2026/05/12 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 云南龙津康佑生物医药有限公司 | 昆明龙津药业股份有限公司 | 国药准字H20264323 | 2026/05/12 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 嘉实（湖南）医药科技有限公司 | 湖南天济草堂制药股份有限公司 | 国药准字H20263961 | 2026/04/14 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 安徽省先锋制药有限公司 | 安徽省先锋制药有限公司 | 国药准字H20263236 | 2026/01/27 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南先施制药有限公司 | 湖南先施制药有限公司 | 国药准字H20256454 | 2025/12/30 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 杭州元素医药有限公司 | 杭州民生药业股份有限公司 | 国药准字H20256446 | 2025/12/30 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南先施制药有限公司 | 湖南先施制药有限公司 | 国药准字H20256455 | 2025/12/30 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏福邦药业有限公司 | 江苏福邦药业有限公司 | 国药准字H20256374 | 2025/12/22 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河北万岁药业有限公司 | 河北万岁药业有限公司 | 国药准字H20256188 | 2025/12/09 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河北万岁药业有限公司 | 河北万岁药业有限公司 | 国药准字H20256187 | 2025/12/09 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江施强制药有限公司 | 浙江施强制药有限公司 | 国药准字H20256056 | 2025/11/25 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 烟台鲁银药业有限公司 | 烟台鲁银药业有限公司 | 国药准字H20255976 | 2025/11/18 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 上海汇伦江苏药业有限公司 | 上海汇伦江苏药业有限公司 | 国药准字H20256001 | 2025/11/18 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 上海汇伦江苏药业有限公司 | 上海汇伦江苏药业有限公司 | 国药准字H20256000 | 2025/11/18 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湘北威尔曼制药股份有限公司 | 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 2025/11/18 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江西汇仁药业股份有限公司 | 江西汇仁药业股份有限公司 | 国药准字H20255978 | 2025/11/18 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江西汇仁药业股份有限公司 | 江西汇仁药业股份有限公司 | 国药准字H20255979 | 2025/11/18 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 悦康药业集团股份有限公司 | 悦康药业集团股份有限公司 | 国药准字H20255898 | 2025/11/12 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 悦康药业集团股份有限公司 | 悦康药业集团股份有限公司 | 国药准字H20255899 | 2025/11/12 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 武汉九珑人福药业有限责任公司 | 重庆博腾药业有限公司 | 国药准字H20255593 | 2025/09/30 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 武汉九珑人福药业有限责任公司 | 重庆博腾药业有限公司 | 国药准字H20255592 | 2025/09/30 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 西洲医药科技（浙江）有限公司 | 浙江北生药业汉生制药有限公司 | 国药准字H20254553 | 2025/06/17 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 昆山培力药品有限公司 | 昆山培力药品有限公司 | 国药准字H20254552 | 2025/06/17 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 郑州德迈药业有限公司 | 浙江华润三九众益制药有限公司 | 国药准字H20254551 | 2025/06/17 | 30mg（按C21H23NO计 ） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 修正药业集团长春高新制药有限公司 | 修正药业集团长春高新制药有限公司 | 国药准字H20254300 | 2025/05/27 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南九典制药股份有限公司 | 湖南九典制药股份有限公司 | 国药准字H20254256 | 2025/05/27 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 上海理想制药有限公司 | 上海理想制药有限公司 | 国药准字H20253016 | 2025/01/02 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 上海理想制药有限公司 | 上海理想制药有限公司 | 国药准字H20253015 | 2025/01/02 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南千金湘江药业股份有限公司 | 宁夏康亚药业股份有限公司 | 国药准字H20249684 | 2024/12/06 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 齐鲁制药有限公司 | 齐鲁制药有限公司 | 国药准字H20249570 | 2024/12/01 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏天士力帝益药业有限公司 | 江苏天士力帝益药业有限公司 | 国药准字H20244358 | 2024/06/28 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏天士力帝益药业有限公司 | 江苏天士力帝益药业有限公司 | 国药准字H20244359 | 2024/06/28 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江西施美药业股份有限公司 | 江西施美药业股份有限公司 | 国药准字H20244309 | 2024/06/28 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江西施美药业股份有限公司 | 江西施美药业股份有限公司 | 国药准字H20244308 | 2024/06/28 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 吉林省申远医药有限责任公司 | 山西同达药业有限公司 | 国药准字H20244117 | 2024/06/25 | 30mg（按C<sub>21</sub>H<sub>23</sub>NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 吉林省申远医药有限责任公司 | 山西同达药业有限公司 | 国药准字H20244118 | 2024/06/25 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 瑞阳制药股份有限公司 | 瑞阳制药股份有限公司 | 国药准字H20243737 | 2024/05/21 | 60mg(按C21H23NO计) | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 瑞阳制药股份有限公司 | 瑞阳制药股份有限公司 | 国药准字H20243736 | 2024/05/21 | 30mg(按C21H23NO计) | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 景时（杭州）药业有限公司 | 浙江赛默制药有限公司 | 国药准字H20243499 | 2024/04/17 | 30mg(按C21H23NO计) | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 景时（杭州）药业有限公司 | 浙江赛默制药有限公司 | 国药准字H20243498 | 2024/04/17 | 60mg(按C21H23NO计) | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 通化万通药业股份有限公司 | 通化万通药业股份有限公司 | 国药准字H20243544 | 2024/04/17 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 乐福思健康产业股份公司 | 湖南九典制药股份有限公司 | 国药准字H20243216 | 2024/02/23 | 30mg(按C21H23NO计) | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广东泉新泉益药业有限公司 | 江苏万高药业股份有限公司 | 国药准字H20243157 | 2024/02/06 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 东北制药集团沈阳第一制药有限公司 | 东北制药集团沈阳第一制药有限公司 | 国药准字H20243117 | 2024/01/30 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东丹红制药有限公司 | 陕西步长制药有限公司 | 国药准字H20234683 | 2023/12/26 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东丹红制药有限公司 | 陕西步长制药有限公司 | 国药准字H20234684 | 2023/12/26 | 60mg (按C21H23NO计) | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江西仁齐制药有限公司 | 江西仁齐制药有限公司 | 国药准字H20234502 | 2023/11/21 | 30mg（ 按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 南京正科医药股份有限公司 | 南京正科医药股份有限公司 | 国药准字H20234541 | 2023/11/21 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 南京正科医药股份有限公司 | 南京正科医药股份有限公司 | 国药准字H20234540 | 2023/11/21 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 海南卓力制药有限公司 | 海南卓力制药有限公司 | 国药准字H20234483 | 2023/11/14 | 30mg（按 C21H23NO 计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 苏州旺山旺水生物医药股份有限公司 | 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20234430 | 2023/10/31 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 烟台市东盛生物科技有限公司 | 蓬莱诺康药业有限公司 | 国药准字H20234349 | 2023/10/24 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 苏州第三制药厂有限责任公司 | 苏州第三制药厂有限责任公司 | 国药准字H20234305 | 2023/10/18 | 60mg(以C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 苏州第三制药厂有限责任公司 | 苏州第三制药厂有限责任公司 | 国药准字H20234304 | 2023/10/18 | 30mg(以C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江西制药有限责任公司 | 江西制药有限责任公司 | 国药准字H20233489 | 2023/04/17 | 30mg(以C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广东赛烽医药科技有限公司 | 海南辉能药业有限公司 | 国药准字H20233362 | 2023/03/24 | 30mg（以C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 西洲医药科技（浙江）有限公司 | 浙江北生药业汉生制药有限公司 | 国药准字H20233168 | 2023/02/14 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20223925 | 2022/12/30 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20223926 | 2022/12/30 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 盖天力医药控股集团制药股份有限公司 | 盖天力医药控股集团制药股份有限公司 | 国药准字H20223754 | 2022/10/11 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏联环药业股份有限公司 | 江苏联环药业股份有限公司 | 国药准字H20213945 | 2021/12/14 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 扬子江药业集团江苏紫龙药业有限公司 | 扬子江药业集团江苏紫龙药业有限公司 | 国药准字H20213932 | 2021/12/14 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东朗诺制药有限公司 | 山东朗诺制药有限公司 | 国药准字H20213748 | 2021/09/24 | 30mg(按C<sub>21</sub>H<sub>23</sub>NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 力品药业（厦门）有限公司 | 厦门力卓药业有限公司 | 国药准字H20213156 | 2021/03/09 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 深圳信立泰药业股份有限公司 | 深圳信立泰药业股份有限公司 | 国药准字H20203552 | 2020/11/04 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 深圳信立泰药业股份有限公司 | 深圳信立泰药业股份有限公司 | 国药准字H20203553 | 2020/11/04 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 四川科伦药业股份有限公司 | 四川科伦药业股份有限公司 | 国药准字H20203190 | 2020/05/07 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 四川科伦药业股份有限公司 | 四川科伦药业股份有限公司 | 国药准字H20203189 | 2020/05/07 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东华铂凯盛生物科技有限公司 | 烟台鲁银药业有限公司 | 国药准字H20203169 | 2020/04/14 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| Berlin-Chemie AG | Menarini - Von Heyden GmbH | H20150563 | 2010/12/10 | 30mg | Imported originator drug (进口原研药品) | CDE |
| Berlin-Chemie AG | Menarini - Von Heyden GmbH | H20150564 | 2010/12/10 | 60mg | Imported originator drug (进口原研药品) | CDE |
| 杭州康恩贝制药有限公司 | 杭州康恩贝制药有限公司 | 国药准字H20266060 | 2026/09/22 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 杭州康恩贝制药有限公司 | 杭州康恩贝制药有限公司 | 国药准字H20266061 | 2026/09/22 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江西施美药业股份有限公司 | 江西施美药业股份有限公司 | 国药准字H20264012 | 2026/04/14 | 30mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江西施美药业股份有限公司 | 江西施美药业股份有限公司 | 国药准字H20264011 | 2026/04/14 | 60mg（按C21H23NO计） | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 67 distinct approval numbers and 49 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 悦康药业集团股份有限公司 | 国药准字H20255898 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010100239 | NHSA |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20223926 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010100381 | NHSA |
| 天方药业有限公司 | 国药准字H20203552 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010100553 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253015 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001010100698 | NHSA |
| 东北制药集团沈阳第一制药有限公司 | 国药准字H20243117 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010101329 | NHSA |
| 盖天力医药控股集团制药股份有限公司 | 国药准字H20223754 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010101403 | NHSA |
| 江苏福邦药业有限公司 | 国药准字H20256374 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010101438 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010101467 | NHSA |
| 江苏天士力帝益药业有限公司 | 国药准字H20244358 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010101500 | NHSA |
| 南京正科医药股份有限公司 | 国药准字H20234541 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010101599 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234304 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010101646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203189 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010102180 | NHSA |
| 河北万岁药业有限公司 | 国药准字H20256187 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010102667 | NHSA |
| 通化万通药业股份有限公司 | 国药准字H20243544 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010103576 | NHSA |
| 修正药业集团长春高新制药有限公司 | 国药准字H20254300 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010103592 | NHSA |
| 昆明正祺医药科技有限公司 | 国药准字H20234349 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010104017 | NHSA |
| 齐鲁制药有限公司 | 国药准字H20249570 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010104021 | NHSA |
| 苏州旺山旺水生物医药股份有限公司 | 国药准字H20234430 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010104131 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20243736 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010104152 | NHSA |
| 山东华铂凯盛生物科技有限公司 | 国药准字H20203169 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010104240 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20263236 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010104339 | NHSA |
| 浙江施强制药有限公司 | 国药准字H20256056 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010104578 | NHSA |
| 浙江莎普爱思药业股份有限公司 | 国药准字H20264855 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010104693 | NHSA |
| 力品药业(厦门)股份有限公司 | 国药准字H20213156 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010104859 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20254256 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010104942 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20249684 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010104960 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010105025 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244309 | 30mg | Not stated by source | XG04BED214A001010105356 | NHSA |
| 江西制药有限责任公司 | 国药准字H20233489 | 30mg(以C21H23NO计) | Not stated by source | XG04BED214A001010105388 | NHSA |
| 江西仁齐制药有限公司 | 国药准字H20234502 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010105407 | NHSA |
| 苏州特瑞药业股份有限公司 | 国药准字H20255105 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010110121 | NHSA |
| 海南红祥旗荣医药科技有限公司 | 国药准字H20213748 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010110323 | NHSA |
| Berlin-Chemie AG | 国药准字HJ20150563 | 30mg | Not stated by source | XG04BED214A001010178278 | NHSA |
| 陕西步长制药有限公司 | 国药准字H20234683 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010180472 | NHSA |
| 扬子江药业集团江苏紫龙药业有限公司 | 国药准字H20213932 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010182147 | NHSA |
| 海南卓力制药有限公司 | 国药准字H20234483 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010182808 | NHSA |
| 山东百诺医药股份有限公司 | 国药准字H20264848 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010183011 | NHSA |
| 海南辉能药业有限公司 | 国药准字H20233362 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010183309 | NHSA |
| 武汉九珑人福药业有限责任公司 | 国药准字H20255592 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010183319 | NHSA |
| 乐福思健康产业股份公司 | 国药准字H20243216 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010183585 | NHSA |
| 湖南先施制药有限公司 | 国药准字H20256454 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010184106 | NHSA |
| 福建广生堂药业股份有限公司 | 国药准字H20233168 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010184209 | NHSA |
| 杭州元素医药有限公司 | 国药准字H20256446 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010184218 | NHSA |
| 云南龙津康佑生物医药有限公司 | 国药准字H20264322 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010184548 | NHSA |
| 吉林省申远医药有限责任公司 | 国药准字H20244117 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010184596 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010184701 | NHSA |
| 郑州德迈药业有限公司 | 国药准字H20254551 | 30mg(按C₂₁H₂₃NO计 ) | Not stated by source | XG04BED214A001010184733 | NHSA |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20223926 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010200381 | NHSA |
| 天方药业有限公司 | 国药准字H20203552 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010200553 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253015 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001010200698 | NHSA |
| 盖天力医药控股集团制药股份有限公司 | 国药准字H20223754 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010201403 | NHSA |
| 江苏福邦药业有限公司 | 国药准字H20256374 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010201438 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010201467 | NHSA |
| 南京正科医药股份有限公司 | 国药准字H20234541 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010201599 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234304 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010201646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203189 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010202180 | NHSA |
| 河北万岁药业有限公司 | 国药准字H20256187 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010202667 | NHSA |
| 修正药业集团长春高新制药有限公司 | 国药准字H20254300 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010203592 | NHSA |
| 昆明正祺医药科技有限公司 | 国药准字H20234349 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010204017 | NHSA |
| 齐鲁制药有限公司 | 国药准字H20249570 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010204021 | NHSA |
| 苏州旺山旺水生物医药股份有限公司 | 国药准字H20234430 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010204131 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20243736 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010204152 | NHSA |
| 山东华铂凯盛生物科技有限公司 | 国药准字H20203169 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010204240 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20263236 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010204339 | NHSA |
| 力品药业(厦门)股份有限公司 | 国药准字H20213156 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010204859 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20254256 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010204942 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20249684 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010204960 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010205025 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244309 | 30mg | Not stated by source | XG04BED214A001010205356 | NHSA |
| 江西制药有限责任公司 | 国药准字H20233489 | 30mg(以C21H23NO计) | Not stated by source | XG04BED214A001010205388 | NHSA |
| 江西仁齐制药有限公司 | 国药准字H20234502 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010205407 | NHSA |
| 海南红祥旗荣医药科技有限公司 | 国药准字H20213748 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010210323 | NHSA |
| Berlin-Chemie AG | 国药准字HJ20150563 | 30mg | Not stated by source | XG04BED214A001010278278 | NHSA |
| 扬子江药业集团江苏紫龙药业有限公司 | 国药准字H20213932 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010282147 | NHSA |
| 山东百诺医药股份有限公司 | 国药准字H20264848 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010283011 | NHSA |
| 海南辉能药业有限公司 | 国药准字H20233362 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010283309 | NHSA |
| 武汉九珑人福药业有限责任公司 | 国药准字H20255592 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010283319 | NHSA |
| 乐福思健康产业股份公司 | 国药准字H20243216 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010283585 | NHSA |
| 福建广生堂药业股份有限公司 | 国药准字H20233168 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010284209 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010284701 | NHSA |
| 郑州德迈药业有限公司 | 国药准字H20254551 | 30mg(按C₂₁H₂₃NO计 ) | Not stated by source | XG04BED214A001010284733 | NHSA |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20223926 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010300381 | NHSA |
| 天方药业有限公司 | 国药准字H20203552 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010300553 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253015 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001010300698 | NHSA |
| 盖天力医药控股集团制药股份有限公司 | 国药准字H20223754 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010301403 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010301467 | NHSA |
| 南京正科医药股份有限公司 | 国药准字H20234541 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010301599 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234304 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010301646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203189 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010302180 | NHSA |
| 昆明正祺医药科技有限公司 | 国药准字H20234349 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010304017 | NHSA |
| 苏州旺山旺水生物医药股份有限公司 | 国药准字H20234430 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010304131 | NHSA |
| 山东华铂凯盛生物科技有限公司 | 国药准字H20203169 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010304240 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20263236 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010304339 | NHSA |
| 力品药业(厦门)股份有限公司 | 国药准字H20213156 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010304859 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20254256 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010304942 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20249684 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010304960 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010305025 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244309 | 30mg | Not stated by source | XG04BED214A001010305356 | NHSA |
| 江西制药有限责任公司 | 国药准字H20233489 | 30mg(以C21H23NO计) | Not stated by source | XG04BED214A001010305388 | NHSA |
| 江西仁齐制药有限公司 | 国药准字H20234502 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010305407 | NHSA |
| Berlin-Chemie AG | 国药准字HJ20150563 | 30mg | Not stated by source | XG04BED214A001010378278 | NHSA |
| 扬子江药业集团江苏紫龙药业有限公司 | 国药准字H20213932 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010382147 | NHSA |
| 山东百诺医药股份有限公司 | 国药准字H20264848 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010383011 | NHSA |
| 乐福思健康产业股份公司 | 国药准字H20243216 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010383585 | NHSA |
| 福建广生堂药业股份有限公司 | 国药准字H20233168 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010384209 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010384701 | NHSA |
| 郑州德迈药业有限公司 | 国药准字H20254551 | 30mg(按C₂₁H₂₃NO计 ) | Not stated by source | XG04BED214A001010384733 | NHSA |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20223926 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010400381 | NHSA |
| 天方药业有限公司 | 国药准字H20203552 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010400553 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253015 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001010400698 | NHSA |
| 盖天力医药控股集团制药股份有限公司 | 国药准字H20223754 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010401403 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234304 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010401646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203189 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010402180 | NHSA |
| 昆明正祺医药科技有限公司 | 国药准字H20234349 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010404017 | NHSA |
| 苏州旺山旺水生物医药股份有限公司 | 国药准字H20234430 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010404131 | NHSA |
| 山东华铂凯盛生物科技有限公司 | 国药准字H20203169 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010404240 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20263236 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010404339 | NHSA |
| 力品药业(厦门)股份有限公司 | 国药准字H20213156 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010404859 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20254256 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010404942 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20249684 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010404960 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010405025 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244309 | 30mg | Not stated by source | XG04BED214A001010405356 | NHSA |
| 江西制药有限责任公司 | 国药准字H20233489 | 30mg(以C21H23NO计) | Not stated by source | XG04BED214A001010405388 | NHSA |
| 江西仁齐制药有限公司 | 国药准字H20234502 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010405407 | NHSA |
| 扬子江药业集团江苏紫龙药业有限公司 | 国药准字H20213932 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010482147 | NHSA |
| 乐福思健康产业股份公司 | 国药准字H20243216 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010483585 | NHSA |
| 福建广生堂药业股份有限公司 | 国药准字H20233168 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010484209 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010484701 | NHSA |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20223926 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010500381 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253015 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001010500698 | NHSA |
| 盖天力医药控股集团制药股份有限公司 | 国药准字H20223754 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010501403 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234304 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010501646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203189 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010502180 | NHSA |
| 昆明正祺医药科技有限公司 | 国药准字H20234349 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010504017 | NHSA |
| 苏州旺山旺水生物医药股份有限公司 | 国药准字H20234430 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010504131 | NHSA |
| 山东华铂凯盛生物科技有限公司 | 国药准字H20203169 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010504240 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20263236 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010504339 | NHSA |
| 力品药业(厦门)股份有限公司 | 国药准字H20213156 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010504859 | NHSA |
| 湖南九典制药股份有限公司 | 国药准字H20254256 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010504942 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20249684 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010504960 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010505025 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244309 | 30mg | Not stated by source | XG04BED214A001010505356 | NHSA |
| 江西制药有限责任公司 | 国药准字H20233489 | 30mg(以C21H23NO计) | Not stated by source | XG04BED214A001010505388 | NHSA |
| 乐福思健康产业股份公司 | 国药准字H20243216 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010583585 | NHSA |
| 福建广生堂药业股份有限公司 | 国药准字H20233168 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010584209 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010584701 | NHSA |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20223926 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010600381 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253015 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001010600698 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234304 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010601646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203189 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010602180 | NHSA |
| 昆明正祺医药科技有限公司 | 国药准字H20234349 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010604017 | NHSA |
| 苏州旺山旺水生物医药股份有限公司 | 国药准字H20234430 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010604131 | NHSA |
| 山东华铂凯盛生物科技有限公司 | 国药准字H20203169 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010604240 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20263236 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010604339 | NHSA |
| 力品药业(厦门)股份有限公司 | 国药准字H20213156 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010604859 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20249684 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010604960 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010605025 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244309 | 30mg | Not stated by source | XG04BED214A001010605356 | NHSA |
| 江西制药有限责任公司 | 国药准字H20233489 | 30mg(以C21H23NO计) | Not stated by source | XG04BED214A001010605388 | NHSA |
| 乐福思健康产业股份公司 | 国药准字H20243216 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010683585 | NHSA |
| 福建广生堂药业股份有限公司 | 国药准字H20233168 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010684209 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010684701 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253015 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001010700698 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234304 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010701646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203189 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010702180 | NHSA |
| 昆明正祺医药科技有限公司 | 国药准字H20234349 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010704017 | NHSA |
| 苏州旺山旺水生物医药股份有限公司 | 国药准字H20234430 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010704131 | NHSA |
| 山东华铂凯盛生物科技有限公司 | 国药准字H20203169 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010704240 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20263236 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010704339 | NHSA |
| 力品药业(厦门)股份有限公司 | 国药准字H20213156 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010704859 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010705025 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244309 | 30mg | Not stated by source | XG04BED214A001010705356 | NHSA |
| 乐福思健康产业股份公司 | 国药准字H20243216 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010783585 | NHSA |
| 福建广生堂药业股份有限公司 | 国药准字H20233168 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010784209 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010784701 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253015 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001010800698 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234304 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010801646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203189 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010802180 | NHSA |
| 昆明正祺医药科技有限公司 | 国药准字H20234349 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010804017 | NHSA |
| 苏州旺山旺水生物医药股份有限公司 | 国药准字H20234430 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010804131 | NHSA |
| 山东华铂凯盛生物科技有限公司 | 国药准字H20203169 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010804240 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20263236 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010804339 | NHSA |
| 力品药业(厦门)股份有限公司 | 国药准字H20213156 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010804859 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010805025 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244309 | 30mg | Not stated by source | XG04BED214A001010805356 | NHSA |
| 乐福思健康产业股份公司 | 国药准字H20243216 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010883585 | NHSA |
| 福建广生堂药业股份有限公司 | 国药准字H20233168 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010884209 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010884701 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253015 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001010900698 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234304 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010901646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203189 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010902180 | NHSA |
| 昆明正祺医药科技有限公司 | 国药准字H20234349 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010904017 | NHSA |
| 山东华铂凯盛生物科技有限公司 | 国药准字H20203169 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001010904240 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20263236 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010904339 | NHSA |
| 力品药业(厦门)股份有限公司 | 国药准字H20213156 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010904859 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010905025 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244309 | 30mg | Not stated by source | XG04BED214A001010905356 | NHSA |
| 乐福思健康产业股份公司 | 国药准字H20243216 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010983585 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001010984701 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253015 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001011000698 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234304 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011001646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203189 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001011002180 | NHSA |
| 昆明正祺医药科技有限公司 | 国药准字H20234349 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011004017 | NHSA |
| 山东华铂凯盛生物科技有限公司 | 国药准字H20203169 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001011004240 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20263236 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011004339 | NHSA |
| 力品药业(厦门)股份有限公司 | 国药准字H20213156 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011004859 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011005025 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244309 | 30mg | Not stated by source | XG04BED214A001011005356 | NHSA |
| 乐福思健康产业股份公司 | 国药准字H20243216 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011083585 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011084701 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253015 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001011100698 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234304 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011101646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203189 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001011102180 | NHSA |
| 昆明正祺医药科技有限公司 | 国药准字H20234349 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011104017 | NHSA |
| 山东华铂凯盛生物科技有限公司 | 国药准字H20203169 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001011104240 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20263236 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011104339 | NHSA |
| 力品药业(厦门)股份有限公司 | 国药准字H20213156 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011104859 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011105025 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244309 | 30mg | Not stated by source | XG04BED214A001011105356 | NHSA |
| 乐福思健康产业股份公司 | 国药准字H20243216 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011183585 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011184701 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253015 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001011200698 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203189 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001011202180 | NHSA |
| 昆明正祺医药科技有限公司 | 国药准字H20234349 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011204017 | NHSA |
| 山东华铂凯盛生物科技有限公司 | 国药准字H20203169 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001011204240 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20263236 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011204339 | NHSA |
| 力品药业(厦门)股份有限公司 | 国药准字H20213156 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011204859 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011205025 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244309 | 30mg | Not stated by source | XG04BED214A001011205356 | NHSA |
| 乐福思健康产业股份公司 | 国药准字H20243216 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011283585 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011284701 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253015 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001011300698 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203189 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001011302180 | NHSA |
| 昆明正祺医药科技有限公司 | 国药准字H20234349 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011304017 | NHSA |
| 山东华铂凯盛生物科技有限公司 | 国药准字H20203169 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001011304240 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20263236 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011304339 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011305025 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244309 | 30mg | Not stated by source | XG04BED214A001011305356 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011384701 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253015 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001011400698 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203189 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001011402180 | NHSA |
| 昆明正祺医药科技有限公司 | 国药准字H20234349 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011404017 | NHSA |
| 山东华铂凯盛生物科技有限公司 | 国药准字H20203169 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001011404240 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20263236 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011404339 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011405025 | NHSA |
| 江西施美药业股份有限公司 | 国药准字H20264012 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011405356 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011484701 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253015 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001011500698 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203189 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001011502180 | NHSA |
| 昆明正祺医药科技有限公司 | 国药准字H20234349 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011504017 | NHSA |
| 山东华铂凯盛生物科技有限公司 | 国药准字H20203169 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001011504240 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20263236 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011504339 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011505025 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011584701 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203189 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001011602180 | NHSA |
| 山东华铂凯盛生物科技有限公司 | 国药准字H20203169 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001011604240 | NHSA |
| 安徽省先锋制药有限公司 | 国药准字H20263236 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011604339 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011605025 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011684701 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011705025 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011784701 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011805025 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011884701 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011905025 | NHSA |
| 广东泉新泉益药业有限公司 | 国药准字H20243157 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001011984701 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001012005025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001012105025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001012205025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001012305025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001012405025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001012505025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001012605025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001012705025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001012805025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001012905025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001013005025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001013105025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001013205025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001013305025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001013405025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001013505025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001013605025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001013705025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001013805025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001013905025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001014005025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001014105025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256003 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001014205025 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20255899 | 30mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020100239 | NHSA |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20223925 | 60mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020100381 | NHSA |
| 天方药业有限公司 | 国药准字H20203553 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001020100553 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253016 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001020100698 | NHSA |
| 盖天力医药控股集团制药股份有限公司 | 国药准字H20223753 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020101403 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020101467 | NHSA |
| 江苏天士力帝益药业有限公司 | 国药准字H20244359 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020101500 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234305 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020101646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203190 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001020102180 | NHSA |
| 昆明正祺医药科技有限公司 | 国药准字H20234349 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020104017 | NHSA |
| 瑞阳制药股份有限公司 | 国药准字H20243737 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020104152 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20249684 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020104960 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020105025 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244309 | 30mg | Not stated by source | XG04BED214A001020105356 | NHSA |
| 江西仁齐制药有限公司 | 国药准字H20234502 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020105407 | NHSA |
| 海南红祥旗荣医药科技有限公司 | 国药准字H20213748 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020110323 | NHSA |
| Berlin-Chemie AG | 国药准字HJ20150564 | 60mg | Not stated by source | XG04BED214A001020178278 | NHSA |
| 陕西步长制药有限公司 | 国药准字H20234684 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001020180472 | NHSA |
| 海南卓力制药有限公司 | 国药准字H20234483 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020182808 | NHSA |
| 山东百诺医药股份有限公司 | 国药准字H20264849 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020183011 | NHSA |
| 武汉九珑人福药业有限责任公司 | 国药准字H20255593 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020183319 | NHSA |
| 湖南先施制药有限公司 | 国药准字H20256455 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020184106 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20254553 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020184209 | NHSA |
| 云南龙津康佑生物医药有限公司 | 国药准字H20264323 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020184548 | NHSA |
| 吉林省申远医药有限责任公司 | 国药准字H20244117 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020184596 | NHSA |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20223925 | 60mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020200381 | NHSA |
| 天方药业有限公司 | 国药准字H20203553 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001020200553 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253016 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001020200698 | NHSA |
| 盖天力医药控股集团制药股份有限公司 | 国药准字H20223753 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020201403 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020201467 | NHSA |
| 江苏天士力帝益药业有限公司 | 国药准字H20244359 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020201500 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234305 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020201646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203190 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001020202180 | NHSA |
| 昆明正祺医药科技有限公司 | 国药准字H20234349 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020204017 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020205025 | NHSA |
| 江西仁齐制药有限公司 | 国药准字H20234502 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020205407 | NHSA |
| 海南红祥旗荣医药科技有限公司 | 国药准字H20213748 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020210323 | NHSA |
| Berlin-Chemie AG | 国药准字HJ20150564 | 60mg | Not stated by source | XG04BED214A001020278278 | NHSA |
| 海南卓力制药有限公司 | 国药准字H20234483 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020282808 | NHSA |
| 山东百诺医药股份有限公司 | 国药准字H20264849 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020283011 | NHSA |
| 西洲医药科技(浙江)有限公司 | 国药准字H20254553 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020284209 | NHSA |
| 吉林省申远医药有限责任公司 | 国药准字H20244117 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020284596 | NHSA |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20223925 | 60mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020300381 | NHSA |
| 天方药业有限公司 | 国药准字H20203553 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001020300553 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253016 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001020300698 | NHSA |
| 盖天力医药控股集团制药股份有限公司 | 国药准字H20223753 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020301403 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020301467 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234305 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020301646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203190 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001020302180 | NHSA |
| 昆明正祺医药科技有限公司 | 国药准字H20234349 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020304017 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020305025 | NHSA |
| 江西仁齐制药有限公司 | 国药准字H20234502 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020305407 | NHSA |
| 海南红祥旗荣医药科技有限公司 | 国药准字H20213748 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020310323 | NHSA |
| 海南卓力制药有限公司 | 国药准字H20234483 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020382808 | NHSA |
| 山东百诺医药股份有限公司 | 国药准字H20264849 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020383011 | NHSA |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20223925 | 60mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020400381 | NHSA |
| 天方药业有限公司 | 国药准字H20203553 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001020400553 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253016 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001020400698 | NHSA |
| 盖天力医药控股集团制药股份有限公司 | 国药准字H20223753 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020401403 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020401467 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234305 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020401646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203190 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001020402180 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020405025 | NHSA |
| 江西仁齐制药有限公司 | 国药准字H20234502 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020405407 | NHSA |
| 海南红祥旗荣医药科技有限公司 | 国药准字H20213748 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020410323 | NHSA |
| 海南卓力制药有限公司 | 国药准字H20234483 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020482808 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253016 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001020500698 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020501467 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234305 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020501646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203190 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001020502180 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020505025 | NHSA |
| 江西仁齐制药有限公司 | 国药准字H20234502 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020505407 | NHSA |
| 海南卓力制药有限公司 | 国药准字H20234483 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020582808 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253016 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001020600698 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020601467 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234305 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020601646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203190 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001020602180 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020605025 | NHSA |
| 江西仁齐制药有限公司 | 国药准字H20234502 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020605407 | NHSA |
| 海南卓力制药有限公司 | 国药准字H20234483 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020682808 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253016 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001020700698 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234305 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020701646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203190 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001020702180 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020705025 | NHSA |
| 江西仁齐制药有限公司 | 国药准字H20234502 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020705407 | NHSA |
| 海南卓力制药有限公司 | 国药准字H20234483 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020782808 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253016 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001020800698 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234305 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020801646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203190 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001020802180 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020805025 | NHSA |
| 江西仁齐制药有限公司 | 国药准字H20234502 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020805407 | NHSA |
| 海南卓力制药有限公司 | 国药准字H20234483 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020882808 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253016 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001020900698 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234305 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020901646 | NHSA |
| 四川科伦药业股份有限公司 | 国药准字H20203190 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001020902180 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020905025 | NHSA |
| 江西仁齐制药有限公司 | 国药准字H20234502 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020905407 | NHSA |
| 海南卓力制药有限公司 | 国药准字H20234483 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001020982808 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253016 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001021000698 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234305 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021001646 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021005025 | NHSA |
| 江西仁齐制药有限公司 | 国药准字H20234502 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021005407 | NHSA |
| 海南卓力制药有限公司 | 国药准字H20234483 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021082808 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253016 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001021100698 | NHSA |
| 苏州第三制药厂有限责任公司 | 国药准字H20234305 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021101646 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021105025 | NHSA |
| 海南卓力制药有限公司 | 国药准字H20234483 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021182808 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253016 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001021200698 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021205025 | NHSA |
| 海南卓力制药有限公司 | 国药准字H20234483 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021282808 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253016 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001021300698 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021305025 | NHSA |
| 海南卓力制药有限公司 | 国药准字H20234483 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021382808 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253016 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001021400698 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021405025 | NHSA |
| 海南卓力制药有限公司 | 国药准字H20234483 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021482808 | NHSA |
| 上海理想制药有限公司 | 国药准字H20253016 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001021500698 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021505025 | NHSA |
| 海南卓力制药有限公司 | 国药准字H20234483 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021582808 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021605025 | NHSA |
| 海南卓力制药有限公司 | 国药准字H20234483 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021682808 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021705025 | NHSA |
| 海南卓力制药有限公司 | 国药准字H20234483 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021782808 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021805025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001021905025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001022005025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001022105025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001022205025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001022305025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001022405025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001022505025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001022605025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001022705025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001022805025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001022905025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001023005025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001023105025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001023205025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001023305025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001023405025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001023505025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001023605025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001023705025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001023805025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001023905025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001024005025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001024105025 | NHSA |
| 湘北威尔曼制药股份有限公司 | 国药准字H20256002 | 60mg(按 C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001024205025 | NHSA |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20223926 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001030100381 | NHSA |
| 天方药业有限公司 | 国药准字H20203552 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001030100553 | NHSA |
| 盖天力医药控股集团制药股份有限公司 | 国药准字H20223754 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001030101403 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001030101467 | NHSA |
| 湖南千金湘江药业股份有限公司 | 国药准字H20249684 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001030104960 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001030105356 | NHSA |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20223926 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001030200381 | NHSA |
| 天方药业有限公司 | 国药准字H20203552 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001030200553 | NHSA |
| 盖天力医药控股集团制药股份有限公司 | 国药准字H20223754 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001030201403 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001030201467 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001030205356 | NHSA |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20223926 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001030300381 | NHSA |
| 天方药业有限公司 | 国药准字H20203552 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001030300553 | NHSA |
| 盖天力医药控股集团制药股份有限公司 | 国药准字H20223754 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001030301403 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001030301467 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001030305356 | NHSA |
| 广州白云山医药集团股份有限公司白云山制药总厂 | 国药准字H20223926 | 30mg( 按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001030400381 | NHSA |
| 天方药业有限公司 | 国药准字H20203552 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001030400553 | NHSA |
| 盖天力医药控股集团制药股份有限公司 | 国药准字H20223754 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001030401403 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001030401467 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001030405356 | NHSA |
| 天方药业有限公司 | 国药准字H20203552 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001030500553 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001030501467 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001030505356 | NHSA |
| 天方药业有限公司 | 国药准字H20203552 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001030600553 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001030601467 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001030605356 | NHSA |
| 天方药业有限公司 | 国药准字H20203552 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001030700553 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001030701467 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001030705356 | NHSA |
| 天方药业有限公司 | 国药准字H20203552 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001030800553 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001030801467 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001030805356 | NHSA |
| 天方药业有限公司 | 国药准字H20203552 | 30mg(按C21H23NO计) | Not stated by source | XG04BED214A001030900553 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001030901467 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001031001467 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001031101467 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001031201467 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001031301467 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20213945 | 30mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001031401467 | NHSA |
| 天方药业有限公司 | 国药准字H20203553 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001040100553 | NHSA |
| 江西施美药业股份有限公司 | 国药准字H20264011 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001040105356 | NHSA |
| 江西施美药业股份有限公司 | 国药准字H20264011 | 60mg(按C₂₁H₂₃NO计) | Not stated by source | XG04BED214A001040205356 | NHSA |
| 天方药业有限公司 | 国药准字H20203553 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001050100553 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244309 | 30mg | Not stated by source | XG04BED214A001050105356 | NHSA |
| 天方药业有限公司 | 国药准字H20203553 | 60mg(按C21H23NO计) | Not stated by source | XG04BED214A001060100553 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244309 | 30mg | Not stated by source | XG04BED214A001060105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001070105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001080105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001090105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001100105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001110105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001120105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001130105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001140105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001150105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001160105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001170105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001180105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001190105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001200105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001210105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001220105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001230105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001240105356 | NHSA |
| 山东鲁抗医药集团赛特有限责任公司 | 国药准字H20244308 | 60mg | Not stated by source | XG04BED214A001250105356 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 20 filings and 11 distinct first applicants.
Supplement 3 · Generic 17
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 山东华铂凯盛生物科技有限公司;安徽泰恩康制药有限公司;烟台鲁银药业有限公司 | CYHB2600607 | Supplement | 2026/03/27 | Not stated by source | CDE |
| 山东济坤生物制药有限公司;山东鲁抗三叶制药有限公司 | CYHS2502714 | Generic | 2025/07/28 | Not stated by source | CDE |
| 山东济坤生物制药有限公司;山东鲁抗三叶制药有限公司 | CYHS2502713 | Generic | 2025/07/28 | Not stated by source | CDE |
| 江苏润邦药业有限公司 | CYHS2502400 | Generic | 2025/07/08 | Not stated by source | CDE |
| 江苏润邦药业有限公司 | CYHS2502399 | Generic | 2025/07/08 | Not stated by source | CDE |
| Berlin-Chemie AG;Menarini-Von Heyden GmbH | JYHB2600308 | Supplement | 2026/06/05 | Not stated by source | CDE |
| Berlin-Chemie AG;Menarini-Von Heyden GmbH | JYHB2600307 | Supplement | 2026/06/05 | Not stated by source | CDE |
| 四川依科制药有限公司 | CYHS2601311 | Generic | 2026/06/05 | Not stated by source | CDE |
| 四川依科制药有限公司 | CYHS2601310 | Generic | 2026/06/05 | Not stated by source | CDE |
| 河北仁合益康药业有限公司 | CYHS2600519 | Generic | 2026/02/25 | Not stated by source | CDE |
| 河北仁合益康药业有限公司 | CYHS2600518 | Generic | 2026/02/25 | Not stated by source | CDE |
| 正大天晴药业集团股份有限公司 | CYHS2600364 | Generic | 2026/02/04 | Not stated by source | CDE |
| 正大天晴药业集团股份有限公司 | CYHS2600363 | Generic | 2026/02/04 | Not stated by source | CDE |
| 国药控股星鲨制药（厦门）有限公司 | CYHS2503878 | Generic | 2025/11/06 | Not stated by source | CDE |
| 国药控股星鲨制药（厦门）有限公司 | CYHS2503877 | Generic | 2025/11/06 | Not stated by source | CDE |
| 中山可可康制药有限公司 | CYHS2503256 | Generic | 2025/09/04 | Not stated by source | CDE |
| 国大（吉林）制药集团有限公司;安徽佳和药业有限公司 | CYHS2503179 | Generic | 2025/08/30 | Not stated by source | CDE |
| 国大（吉林）制药集团有限公司;安徽佳和药业有限公司 | CYHS2503178 | Generic | 2025/08/30 | Not stated by source | CDE |
| 河南君善生物技术有限公司;济南高华制药有限公司 | CYHS2501315 | Generic | 2025/04/08 | Not stated by source | CDE |
| 河南君善生物技术有限公司;济南高华制药有限公司 | CYHS2501314 | Generic | 2025/04/08 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 7 filings and 4 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 植恩生物技术股份有限公司 | CYHS2602001 | Generic | 2026/08/13 | Not stated by source | CDE |
| 四川依科制药有限公司 | CYHS2601311 | Generic | 2026/06/05 | Not stated by source | CDE |
| 四川依科制药有限公司 | CYHS2601310 | Generic | 2026/06/05 | Not stated by source | CDE |
| 河北仁合益康药业有限公司 | CYHS2600519 | Generic | 2026/02/25 | Not stated by source | CDE |
| 河北仁合益康药业有限公司 | CYHS2600518 | Generic | 2026/02/25 | Not stated by source | CDE |
| 正大天晴药业集团股份有限公司 | CYHS2600364 | Generic | 2026/02/04 | Not stated by source | CDE |
| 正大天晴药业集团股份有限公司 | CYHS2600363 | Generic | 2026/02/04 | Not stated by source | CDE |
API registrations
Non-component matches: 22 companies with A status and 4 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 盐酸达泊西汀 | 安徽悦康凯悦制药有限公司 | Y20240001062 | A | Exact ingredient | 2026/03/24 | CDE |
| 盐酸达泊西汀 | 宿州亿帆药业有限公司 | Y20240000539 | A | Exact ingredient | 2025/11/21 | CDE |
| 盐酸达泊西汀 | 长春海悦药业股份有限公司 | Y20230001357 | A | Exact ingredient | 2025/08/30 | CDE |
| 盐酸达泊西汀 | 杨凌吉泰药业有限公司 | Y20230000891 | A | Exact ingredient | 2025/12/03 | CDE |
| 盐酸达泊西汀 | 金鸿药业股份有限公司 | Y20220001243 | A | Exact ingredient | 2024/11/26 | CDE |
| 盐酸达泊西汀 | 天方药业有限公司 | Y20220000891 | A | Exact ingredient | 2025/03/04 | CDE |
| 盐酸达泊西汀 | 湖南九典宏阳制药有限公司 | Y20220000461 | A | Exact ingredient | 2025/04/24 | CDE |
| 盐酸达泊西汀 | 浙江赛默制药有限公司 | Y20220000392 | A | Exact ingredient | 2025/06/07 | CDE |
| 盐酸达泊西汀 | 瑞阳制药股份有限公司 | Y20210000781 | A | Exact ingredient | 2023/07/17 | CDE |
| 盐酸达泊西汀 | 海南辉能药业有限公司 | Y20210000324 | A | Exact ingredient | 2023/03/27 | CDE |
| 盐酸达泊西汀 | 浙江北生药业汉生制药有限公司 | Y20210000371 | A | Exact ingredient | 2023/08/11 | CDE |
| 盐酸达泊西汀 | 广州白云山医药集团股份有限公司白云山化学制药厂 | Y20210000138 | A | Exact ingredient | 2026/11/05 | CDE |
| 盐酸达泊西汀 | 江苏威奇达药业有限公司 | Y20200000944 | A | Exact ingredient | 2024/01/17 | CDE |
| 盐酸达泊西汀 | Optimus Drugs Private Limited | Y20200000869 | I | Exact ingredient | 2020/08/28 | CDE |
| 盐酸达泊西汀 | Maithri Drugs Private Limited. | Y20200000563 | A | Exact ingredient | 2026/10/31 | CDE |
| 盐酸达泊西汀 | 山东特珐曼药业有限公司 | Y20200000439 | A | Exact ingredient | 2026/09/30 | CDE |
| 盐酸达泊西汀 | 江苏联环药业股份有限公司 | Y20190021253 | A | Exact ingredient | 2022/10/31 | CDE |
| 盐酸达泊西汀 | 东北制药集团股份有限公司 | Y20200000155 | A | Exact ingredient | 2026/06/25 | CDE |
| 盐酸达泊西汀 | 扬子江药业集团江苏海慈生物药业有限公司 | Y20190021188 | A | Exact ingredient | 2026/08/25 | CDE |
| 盐酸达泊西汀 | Ami Lifesciences Pvt.Ltd. | Y20180001185 | I | Exact ingredient | 2025/05/16 | CDE |
| 盐酸达泊西汀 | 山东朗诺制药有限公司 | Y20180001416 | A | Exact ingredient | 2026/10/14 | CDE |
| 盐酸达泊西汀 | 惠州信立泰药业有限公司 | Y20180000858 | A | Exact ingredient | 2025/08/30 | CDE |
| 盐酸达泊西汀 | SYMED LABS LIMITED | Y20180000262 | A | Exact ingredient | 2026/08/12 | CDE |
| 盐酸达泊西汀 | 江苏盛迪医药有限公司 | Y20170002079 | I | Exact ingredient | — | CDE |
| 盐酸达泊西汀 | 四川科伦药业股份有限公司 | Y20180000136 | A | Exact ingredient | 2025/04/23 | CDE |
| 盐酸达泊西汀 | 广州朗圣药业有限公司 | Y20170000967 | I | Exact ingredient | — | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
-
2026/11/05No longer listed under review
国源国药（广东）制药集团有限公司
CYHS2502664
Fact date: 2026/11/05 · Site observation date: 2026/11/05
Accepted: 2025/07/23
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/11/05No longer listed under review
国源国药（广东）制药集团有限公司
CYHS2502662
Fact date: 2026/11/05 · Site observation date: 2026/11/05
Accepted: 2025/07/23
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/11/03Marketing application approved
成都恒瑞制药有限公司
CYHS2501793 · 国药准字H20266450
Fact date: 2026/11/03 · Publication date: 2026/11/05 · Site observation date: 2026/11/06
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 76 ↗ -
2026/10/28Notification delivery
植恩生物技术股份有限公司
CYHS2602001
Fact date: 2026/10/28 (Publication date) · Publication date: 2026/10/28 · Site observation date: 2026/11/03
Notification delivered; the specific outcome remains to be checked.
View source · Table row 23 ↗ -
2026/08/13Accepted
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Dapoxetine Hydrochloride Tablets
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy